Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives

Breast Cancer. 2021 May;28(3):539-555. doi: 10.1007/s12282-021-01231-2. Epub 2021 Mar 4.

Abstract

Macrophages are phagocytic sentinel cells of the immune system that are central to both innate and adaptive immune responses and serve as the first line of defense against pathogenic insults to tissues. In the tumor microenvironment, tumor-derived factors induce monocyte polarization towards a pro-tumor phenotype. The pro-tumor macrophages regulate key steps in tumorigenicity including tumor growth, angiogenesis, immune suppression, and metastasis. Macrophage infiltration in solid tumors correlates with poor prognosis and resistance to chemotherapy in most cancers. Here in this review, we will shed light on tumor-associated macrophages (TAMs) in regulating tumorigenicity and TAMs as a prognostic biomarker. Also, we will review the recent advances in targeting TAMs to increase the prognosis of cancer patients.

Keywords: Cancer; Immunosuppression; Monocyte recruitment; Prognosis; Reprogramming TAMs; TAMs; Tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology*
  • Disease Progression
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Molecular Targeted Therapy / methods
  • Neovascularization, Pathologic
  • Tumor Microenvironment / immunology
  • Tumor-Associated Macrophages / immunology*

Substances

  • Biomarkers, Tumor